Effect of timing of norepinephrine administration on prognosis of patients with septic shock

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044071

Enrollment

Unknown

Registered

2021-03-09

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock

Interventions

early group:none

late group:none

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Adults (aged >=18 years old); 2. Patients with septic shock; 3. Norepinephrine (the only vasoactive drug) was used to maintain target MAP >= 65 mmHg; 4. Sodium bicarbonate Ringer injection was used for initial volume recovery (30ml /kg).

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Patients with end-stage renal disease; 3. Patients with AKI before admission; 4. Patients included in other trials; 5. Other reasons that the investigator considers inappropriate to participate in the study.

Design outcomes

Primary

Measure	Time frame
28-day mortality;	—

Countries

China

Contacts

Public ContactYuting Li

Jilin University

liyuting@jlu.edu.cn+86 13943179756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026